RÉSUMÉ
BACKGROUND: The physiological disturbances leading to lymphoedema after breast cancer surgery are poorly understood. Damage to sympathetic nerves during axillary lymph node dissection (ALND), leading to increased capillary fluid filtration, was investigated as a possible contributory factor. METHODS: The integrity of the upper limb sympathetic nervous system was tested in 36 patients before, and 3 and 12 months after ALND. Forearm vascular resistance (FVR), calculated from forearm blood flow and mean systemic arterial pressure, was measured before and after exposure to lower-body negative pressure. Forearm venous compliance was measured using (99m)Tc-labelled autologous erythrocytes and radionuclide plethysmography before and after cold water immersion of the feet. RESULTS: There were clear changes in FVR and venous compliance in response to sympathetic stimulation but no differences attributable to surgery or between the nine patients who developed lymphoedema and the 27 who did not; nor were there differences between the two arms. There was a trend towards lower preoperative FVR in patients who developed lymphoedema. CONCLUSION: Lymphoedema is not the result of sympathetic nerve damage sustained during ALND. Preoperative FVR may help predict who will get lymphoedema following this surgery.
Sujet(s)
Tumeurs du sein/chirurgie , Lymphadénectomie/effets indésirables , Lymphoedème/étiologie , Système nerveux sympathique/traumatismes , Traumatismes du système nerveux/étiologie , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Aisselle , Femelle , Avant-bras/vascularisation , Humains , Adulte d'âge moyen , Période postopératoire , Soins préopératoires , Résistance vasculaire/physiologieRÉSUMÉ
Breast cancer-related lymphoedema (BCRL) is a chronic swelling of the upper limb following surgery to axillary lymph nodes. This clinical literature review considers the risk factors that have been identified for the development of BCRL: the extent of surgery to the breast and the axilla, radiotherapy, nodal status, infection and patient characteristics such as BMI and patient age. The management of BCRL is primarily conservative, but the evidence for pharmacological and surgical approaches is also considered.
Sujet(s)
Tumeurs du sein/chirurgie , Lymphadénectomie/effets indésirables , Lymphoedème/étiologie , Lymphoedème/thérapie , Mastectomie/effets indésirables , Aisselle , Tumeurs du sein/anatomopathologie , Femelle , Humains , Lymphoedème/diagnosticSujet(s)
Tumeurs du sein/chirurgie , Lymphoedème/étiologie , Bras/vascularisation , Aisselle , Tumeurs du sein/complications , Tumeurs du sein/physiopathologie , Femelle , Études de suivi , Humains , Lymphadénectomie/méthodes , Lymphoedème/physiopathologie , Complications postopératoires/étiologie , Complications postopératoires/physiopathologieRÉSUMÉ
BACKGROUND: "Inflammatory" breast cancer is a rare and very aggressive form of the disease characterised by rapid onset and dismal outcome. METHODS: This review describes the clinical and molecular aspects of inflammatory breast cancer. The relevant English language literature on of inflammatory breast cancer was searched via Medline and ISI Web of Knowledge Cross Search (1924-2005), cross-referencing with key articles on the subject. RESULTS AND CONCLUSION: An increasing body of evidence demonstrates that inflammatory breast cancer is a unique form of breast cancer. A prompt diagnosis and multidisciplinary approach (based on neoadjuvant chemotherapy, loco-regional treatment with surgery and/or radiotherapy, followed in some cases by adjuvant systemic therapy) are the two factors most likely to have an impact on survival. As the molecular basis of the disease is becoming increasingly more defined, new potential therapeutic targets may arise in the future.